Archives of Dermatological Research

, Volume 305, Issue 2, pp 105–112 | Cite as

Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI

  • Jorge Romaní
  • Assumpta Caixàs
  • Victoria Ceperuelo-Mallafré
  • José Manuel Carrascosa
  • Miquel Ribera
  • Mercedes Rigla
  • Joan Vendrell
  • Jesús Luelmo
Original Paper

Abstract

Psoriasis has been related to metabolic syndrome (MS). Adipocytokines produced by white adipose tissue may be involved in the pathogenesis of psoriasis and its association with MS. Our objectives were to characterize the profile of a number of different inflammatory and atherogenic markers, vitamins, adipokines and cytokines and their potential involvement in MS in patients with moderate-to-severe psoriasis without joint involvement compared to anthropometrically matched controls, and to evaluate correlation with severity of the skin disease and changes after narrow-band UVB (NB-UVB) phototherapy. We designed a prospective cross-sectional study. Baseline waist circumference, body fat composition, lipid, carbohydrate and calcium metabolism profile, inflammation markers, homocysteine and vitamins D, B6, B12 and folic acid, leptin, resistin, omentin, lipocalin-2, adipocyte fatty acid-binding protein, retinol-binding protein-4 (RBP-4), interleukin-6, soluble tumour necrosis factor receptor 1 (sTNFR1) and interleukin-17 of 50 psoriasis patients and 50 gender, age and body mass index-matched controls were recorded, then evaluated after NB-UVB in the patients. The patients had higher baseline serum concentrations of leptin, RBP-4, lipocalin-2 and sTNFR1. Baseline psoriasis area and severity index correlated with serum concentrations of RBP-4 and lipocalin-2 only. Principal components analysis disclosed a component including vitamins B12, B6, folic acid, calcidiol and HDL-cholesterol that was only present in healthy controls and opposed to a cluster of variables which promote MS. This component was absent in the patients. Our results point to lipocalin-2 and RBP-4 as relevant mediators of the trend towards MS in psoriatic patients.

Keywords

Psoriasis Adipokines Phototherapy Comorbidities Metabolic syndrome 

Notes

Acknowledgements

This study was financially supported by a research grant from the Comite Institucional de Recerca of the Fundació Parc Taulí. The sponsors had no role in the design and conduct of the study; in the collection, analysis and interpretation of data; or in the preparation, review or approval of the manuscript.

Conflict of interest

None.

References

  1. 1.
    Armstrong AW, Voyles SV, Armstrong EJ et al (2011) A tale of two plaques: convergent mechanisms of T-cell mediated inflammation in psoriasis and atherosclerosis. Exp Dermatol 20:544–549PubMedCrossRefGoogle Scholar
  2. 2.
    Boehncke WH, Boehncke S, Tobin AM, Kirby B (2011) The “psoriatic march”: a concept of how severe psoriasis may drive cardiovascular morbidity. Exp Dermatol 20:303–307PubMedCrossRefGoogle Scholar
  3. 3.
    Cabré A, Babio N, Lázaro I et al (2012) FABP4 predicts atherogenic dyslipidemia development. The PREDIMED study. Atherosclerosis 222:229–234PubMedCrossRefGoogle Scholar
  4. 4.
    Cantarini L, Simonini G, Fioravanti A et al (2011) Circulating levels of the adipokines vaspin and omentin in patients with juvenile idiopathic arthritis, and relation to disease activity. Clin Exp Rheumatol 29:1044–1048PubMedGoogle Scholar
  5. 5.
    Carr DB, Utzschneider KM, Hull RL et al (2004) Intra-abdominal fat is a major determinant of the national cholesterol education program adult treatment panel III criteria for the metabolic syndrome. Diabetes 53:2087–2094PubMedCrossRefGoogle Scholar
  6. 6.
    Chen YJ, Wu CY, Shen JL et al (2008) Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome. Arch Dermatol 144:1571–1575PubMedCrossRefGoogle Scholar
  7. 7.
    Chodorowska G (1998) Plasma concentrations of IFN-gamma and TNF-alpha in psoriatic patients before and after local treatment with dithranol ointment. J Eur Acad Dermatol Venereol 10(2):147–151PubMedGoogle Scholar
  8. 8.
    Coimbra S, Oliveira H, Reis et al (2010) Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy. J Eur Acad Dermatol Venereol 24:1386–1394PubMedCrossRefGoogle Scholar
  9. 9.
    Coimbra S, Oliveira H, Reis F et al (2010) Interleukin (IL) 22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumor necrosis factor-alpha levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy. Br J Dermatol 163:1282–1290PubMedCrossRefGoogle Scholar
  10. 10.
    Corripio R, Gónzalez-Clemente JM, Pérez-Sánchez J et al (2010) Weight loss in prepubertal obese children is associated with a decrease in adipocyte fatty-acid-binding protein without changes in lipocalin-2: a 2 year longitudinal study. Eur J Endocrinol 163:887–893PubMedCrossRefGoogle Scholar
  11. 11.
    De Souza Batista CM, Yang RZ, Lee MJ et al (2007) Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56:1655–1661PubMedCrossRefGoogle Scholar
  12. 12.
    El-Mesallamy HO, Hamdy NM, Sallam AA (2012) Effect of obesity and glycemic control on serum lipocalins and insulin-like growth factor axis in type 2 diabetic patients. Acta Diabetol. doi:  10.1007/s00592-012-0373-6
  13. 13.
    Gerdes S, Osadtschy S, Rostami-Yazdi M et al (2012) Leptin, adiponectin, visfatin and retinol-binding protein-4—mediators of comorbidities in patients with psoriasis? Exp Dermatol 21:43–47PubMedCrossRefGoogle Scholar
  14. 14.
    Gerdes S, Rostami-Yazdi M, Mrowietz U (2011) Adipokines and psoriasis. Exp Dermatol 20(2):81–87PubMedCrossRefGoogle Scholar
  15. 15.
    Gisondi P, Lora V, Bonauguri C et al (2012) Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab. Br J Dermatol. doi:  10.1111/bjd.12118
  16. 16.
    Graham TE, Yang Q, Bluher M et al (2006) Retinol binding protein-4 and insulin resistance in lean, obese and diabetic subjects. New Eng J Med 354(24):2552–2563PubMedCrossRefGoogle Scholar
  17. 17.
    Ismail SA, Mohamed SA (2012) Serum levels of visfatin and omentin-1 in patients with psoriasis and their relation to disease severity. Br J Dermatol 167:436–439PubMedCrossRefGoogle Scholar
  18. 18.
    Jin Y, Zhang F, Yang S et al (2008) Combined effects of HLA-Cw6, body mass index and waist–hip ratio on psoriasis vulgaris in Chinese han population. J Dermatol Sci 52:123–129PubMedCrossRefGoogle Scholar
  19. 19.
    Johnston A, Arnadottir S, Gudjonsson JE (2008) Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation. Br J Dermatol 159:342–350PubMedCrossRefGoogle Scholar
  20. 20.
    Kamata M, Tada Y, Tatsuta A et al (2012) Serum lipocalin-2 levels are increased in patients with psoriasis. Clin Exp Dermatol 37:296–299PubMedCrossRefGoogle Scholar
  21. 21.
    Kaur S, Zilmer K, Leping V, Zilmer M (2011) The levels of adiponectin and leptin and their relation to other markers of cardiovascular risk in patients with psoriasis. J Eur Acad Dermatol Venereol 25:1328–1333PubMedCrossRefGoogle Scholar
  22. 22.
    Mallbris L, O’Brien KP, Hulthén A et al (2002) Neutrophil gelatinase-associated lipocalin is a marker for dysregulated keratinocyte differentiation in human skin. Exp Dermatol 11:584–591PubMedCrossRefGoogle Scholar
  23. 23.
    Meijer K, De Vries M, Al-Lahham S et al (2011) Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages. Plos One 6:1–13Google Scholar
  24. 24.
    Mohamed-Ali V, Goodrick S, Rawesh A et al (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 12:4196–4200CrossRefGoogle Scholar
  25. 25.
    Nakajima H, Nakajima K, Tarutani M et al (2011) Kinetics of circulating Th17 cytokines and adipokines in psoriasis patients. Arch Dermatol Res 303:451–455PubMedCrossRefGoogle Scholar
  26. 26.
    Pearson K (1902) “On lines and planes of closest fit to systems of points in space” (PDF). Philos Mag 2:559–572Google Scholar
  27. 27.
    Ridker PM, Rifai N, Stampfer MJ, Hennekens CH (2000) Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767PubMedCrossRefGoogle Scholar
  28. 28.
    Romaní J, Caixàs A, Carrascosa JM, Ribera M, Rigla M, Luelmo J (2012) Effect of narrow-band UVB therapy on inflammatory markers and body fat composition in moderate to severe psoriasis. Br J Dermatol 166:1237–1244PubMedCrossRefGoogle Scholar
  29. 29.
    Schäffler A, Neumeier M, Herfarth H et al (2005) Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 1732(1–3):96–102PubMedGoogle Scholar
  30. 30.
    Seo SJ, Ahn JY, Hong CK et al (2006) Expression of neutrophil gelatinase-associated lipocalin in skin epidermis. J Invest Dermatol 126:510–512PubMedCrossRefGoogle Scholar
  31. 31.
    Serwin AB, Sokolowska M, Chodynicka B (2005) Soluble tumor necrosis factor alpha receptor type 1 in psoriasis patients treated with narrowband ultraviolet B. Photodermatol Photoimmunol Photomed 21:210–211PubMedCrossRefGoogle Scholar
  32. 32.
    Sethi JK, Hotamisligil GS (1999) The role of TNF alpha in adipocyte metabolism. Semin Cell Dev Biol 10:19–29PubMedCrossRefGoogle Scholar
  33. 33.
    Shibata S, Saeki H, Tada Y (2009) Serum high molecular weight adiponectin levels are decreased in psoriasis patients. J Dermatol Sci 55:62–63PubMedCrossRefGoogle Scholar
  34. 34.
    Tan BK, Adya R, Randeva HS (2010) Omentin: a novel link between inflammation, obesity, and cardiovascular disease. Trends Cardiovasc Med 20:143–148PubMedCrossRefGoogle Scholar
  35. 35.
    Takahashi H, Tsuji H, Takahashi I et al (2008) Plasma adiponectin and leptin levels in Japanese patients with psoriasis. Br J Dermatol 159(5):1207–1208PubMedGoogle Scholar
  36. 36.
    Vaisbuch E, Mazaki-Tovi S, Kusanovic JP et al (2010) Retinol binding protein 4: an adipokine associated with intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med 23:111–119PubMedCrossRefGoogle Scholar
  37. 37.
    Wang Y, Chen J, Zhao Y et al (2008) Psoriasis is associated with increased levels of serum leptin. Br J Dermatol 158:1134–1173PubMedCrossRefGoogle Scholar
  38. 38.
    Zhang J, Wu Y, Zhang Y et al (2008) The role of lipocalin-2 in the regulation of inflammation in adipocytes and macrophages. Mol Endocrinol 22:1416–1426PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Jorge Romaní
    • 1
    • 6
  • Assumpta Caixàs
    • 2
  • Victoria Ceperuelo-Mallafré
    • 3
  • José Manuel Carrascosa
    • 5
  • Miquel Ribera
    • 1
  • Mercedes Rigla
    • 2
  • Joan Vendrell
    • 4
  • Jesús Luelmo
    • 1
  1. 1.Department of Dermatology, Hospital Universitari Parc Taulí, Hospital de Sabadell, Corporació Sanitària Parc Taulí, Institut Universitari Parc Taulí, UABUniversitat Autònoma de BarcelonaBellaterraSpain
  2. 2.Department of Diabetes, Endocrinology and Nutrition, Hospital Universitari Parc Taulí, Hospital de Sabadell, Corporació Sanitària Parc Taulí, Institut Universitari Parc Taulí, UABUniversitat Autònoma de BarcelonaBellaterraSpain
  3. 3.Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y la Nutrición (CIBERobn)Hospital Clínico Virgen de la VictoriaMálagaSpain
  4. 4.Department of EndocrinologyHospital Universitari Joan XXIIITarragonaSpain
  5. 5.Department of Dermatology, Hospital Universitari Germans Trias i PujolUniversitat Autònoma de BarcelonaBadalonaSpain
  6. 6.Hospital Parc TaulíSabadellSpain

Personalised recommendations